Viemed Healthcare (VMD)
(Delayed Data from NSDQ)
$7.10 USD
+0.14 (2.01%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $7.09 -0.01 (-0.14%) 6:02 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
VMD 7.10 +0.14(2.01%)
Will VMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VMD based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for VMD
Viemed Healthcare Inc (VMD) Q2 2025 Earnings Call Highlights: Strong Organic Growth and ...
Q2 2025 Viemed Healthcare Inc Earnings Call Transcript
Viemed Healthcare reports Q2 results
Viemed Healthcare Inc Q2 2025 Earnings: EPS of $0.08 and Revenue of $63. ...
Viemed Healthcare Announces Second Quarter 2025 Financial Results | VMD Stock News